symbol CRY
会社名 CryoLife Inc. (CRYOLIFE)
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 クライオライフ(CryoLife Inc.)は医療機器の製造者とプロセッサーであり、医療機器および心臓外科手術に応用する移植可能なヒト組織の流通を行う。同社は医療機器および保存サービス、二つのセグメントで事業を展開する。医療機器セグメントはBioGlue Surgical Adhesive、BioFoam Surgical Matrixなどの医療機器、弁と外科用製品、CardioGenesis心臓レーザー治療製品ライン、PerClotとPhotoFixを含む。PhotoFixはグルタルアルデヒドの必要ない色素媒介光固定プロセスを用いて安定化された心膜パッチである。保存サービスセグメントは心臓および血管組織の保存などの外部サービスを含む。CryoLife iによって配布される心臓および血管組織はCryoLifeのSynerGraft技術を利用して処理されたCryoValve SG肺心臓弁およびCryoPatch SG肺心臓パッチを含む。  クライオライフは米国の医療用機器関連製造会社。心臓と血管アプリケ―ションのための医療用デバイスの開発、製造、商品化。また、移植用のヒト組織の保管と流通を行う。冠動脈疾患患者にレ―ザ―コンソ―ルシステム、狭心症患者に使い捨ての光ファイバ―ハンドピ―スを使用して治療。その他、末期腎疾患患者用の血液透析機器の販売。  Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
本社所在地 1655 Roberts Boulevard N.W. Kennesaw GA 30144 USA
代表者氏名 James Patrick Mackin
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 770-419-3355
設立年月日 30682
市場名 NYSE(ニューヨーク証券取引所)
従業員数 1100人
EBITDA (百万ドル) 27.40700
時価総額 (百万ドル) 1103.43100
売上高 (百万ドル) 262.84100
企業価値(EV) (百万ドル) 1285.48900
当期純利益 (百万ドル) -3.05100
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Cryolife Inc revenues increased 39% to $262.8M. Net loss applicable to common stockholders excluding extraordinary items totaled $3.1M vs. income of $3.4M. Revenues reflect Medical Devices segment increase of 57% to $187.4M Preservation services segment increase of 8% to $75.4M International segment increase from $54.6M to $118.2M United States segment increase of 7% to $144.7M.



   Analyzing CryoLife (NYSE:CRY) and Vasamed (OTCMKTS:VSMD)  2021/12/24 06:56:41 Dakota Financial News
Vasamed (OTCMKTS:VSMD) and CryoLife (NYSE:CRY) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings. Analyst Ratings This is a summary of recent recommendations and price targets for Vasamed and CryoLife, as provided []
   New York State Teachers Retirement System Sells 700 Shares of CryoLife, Inc. (NYSE:CRY)  2021/12/23 09:20:46 Transcript Daily
New York State Teachers Retirement System lowered its stake in shares of CryoLife, Inc. (NYSE:CRY) by 0.8% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 88,257 shares of the medical equipment providers stock after selling 700 shares during the quarter. New York State Teachers Retirement Systems holdings in CryoLife were worth $1,967,000 as []
   Amy Horton Sells 2,500 Shares of CryoLife, Inc. (NYSE:CRY) Stock  2021/12/12 11:46:41 Transcript Daily
CryoLife, Inc. (NYSE:CRY) CAO Amy Horton sold 2,500 shares of CryoLife stock in a transaction dated Wednesday, December 8th. The shares were sold at an average price of $18.57, for a total value of $46,425.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. []
   Insights on the Medical Adhesives and Sealants Global Market to 2027 - Featuring 3M, Baxter International and CryoLife Among Others -  2021/12/07 20:18:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Medical Adhesives and Sealants - Global Market Trajectory & Analytics" report has been added to''s offering. Amid the COVID-19 crisis, the global market for Medical Adhesives and Sealants estimated at US$10.3 Billion in the year 2020, is projected to reach a revised size of US$15.2 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. Acrylic, one of the segments analyzed in the report, is projected to record a 4.7
   State of Alaska Department of Revenue Has $639,000 Holdings in CryoLife, Inc. (NYSE:CRY)  2021/12/01 11:44:41 Transcript Daily
State of Alaska Department of Revenue lifted its holdings in CryoLife, Inc. (NYSE:CRY) by 6.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,672 shares of the medical equipment providers stock after acquiring an additional 1,615 shares during the period. State of Alaska Department of Revenues []
   Worldwide Soft Tissue Repair Industry to 2028 - Featuring Allergan, Baxter International and Stryker Among Others -  2021/11/03 13:59:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Soft Tissue Repair Market 2021-2028" report has been added to''s offering. The global soft tissue repair market is expected to rise with a CAGR of 6.16% in the estimated period 2021-2028. Companies Mentioned Allergan Athersys Inc Bard Peripheral Vascular Inc Baxter International Inc Becton Dickinson and Company (Bd) Boston Scientific Corporation Cryolife Inc Johnson & Johnson Integra Lifesciences Corporation Medtronic plc Organogene
   Comparing CryoLife (NYSE:CRY) & PAVmed (NASDAQ:PAVM)  2021/10/28 11:14:41 Transcript Daily
CryoLife (NYSE:CRY) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings. Analyst Recommendations This is a breakdown of recent ratings for CryoLife and PAVmed, as provided by []
   Bone Glue Market Key Players | Cryolife, Luna Innovationsorporated., Cohera Medical, Tissuemed Ltd  2021/10/28 11:10:47 OpenPR
The global Bone Glue market was valued at $1,981.77 Mn in 2020 and is expected to reach $3,081.65 Mn by 2028 growing at a CAGR of 5.7% over the forecast period. The concept of a “bone glue” to repair
   CryoLife (CRY) to Release Quarterly Earnings on Thursday  2021/10/28 08:20:41 Transcript Daily
CryoLife (NYSE:CRY) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 4th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. Parties interested in participating in the companys conference call can do so using this link. CryoLife (NYSE:CRY) last posted its quarterly earnings results []
   Hemostats Market by Top International players are Baxter International Inc., Stryker, CryoLife Inc., Integra Life Sciences and more. Baxter was the leading player in the global hemostatic agents market in 2017, Fortune business Insights predict the value  2021/10/21 05:04:17 OpenPR
Hemostats Market Size | 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. The Global Hemostats
   Global Transcatheter Heart Valve Replacement Devices Market Report 2021 Featuring Edwards Lifesciences, Medtronic, Livanova, Abbott, Boston Scientific, CryoLife  2021/09/03 08:03:32 Benzinga
Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "Transcatheter Heart Valve Replacement Devices - Market Insights, Competitive Landscape and Market Forecast - 2026" drug pipelines has been added to''s offering. The Transcatheter Heart Valve Replacement Devices (THVR) market report provides an overview of THVR, applications of THVR as well as its PEST Analysis. Additionally, the report provides insight on the THVR market share of the individual THVR, current and forecasted THVR market size from 2018 to 2026, segmented by seven major markets. The report also covers the market drivers, market barriers and unmet needs to curate the best of opportunities and assesses underlying potential of the market. Transcatheter Heart Valve Replacement Devices (THVR) - Competitive Analysis This segment of the report provides a brief competitive analysis of THVR, to help understand the competition in the market. It gives a comparative understanding of the products based on types. List of Companies: Edwards Lifesciences, Medtronic, Livanova plc, Abbott, Boston Scientific Corporation, CryoLife Inc among others.
   Organ and Tissue Transplantation Market Skyrocketing US$ 25 Bn by 2021-28 | CryoLife, Folio Biosciences, Arthrex, Abbvie, Zimmer Biomet, Medtronic, Novartis AG, Stryker, BiolifeSolutions, Teva, Veloxis  2021/08/31 09:39:23 OpenPR
Global Tissue and Organ Transplantation Market to Surpass US$ 25.6 Billion at CAGR of +9% by 2028. A transplant is an organ, tissue or a group of cells removed from one person (the donor) and surgically transplanted into another person (the
   Endovascular Aneurysm Repair Devices Market Useful Survey Report Predicts Astounding Growth by 2027, Industry Players - Getinge Group, Endologix, Cardiatis, CryoLife (Jotec GmbH), BiFlow Medical, EndoSpan, Lemaitre Vascular  2021/08/24 13:17:30 OpenPR
The Endovascular Aneurysm Repair Devices Market is expected to grow at a CAGR of 6.1 % and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020 Recent research from Decisive Markets Insights looks at the
   Global $167 BN Regenerative Medicine Markets, 2021-2029 with Amgen, Novartis, Medtronic., Stryker, CryoLife, Integra LifeSciences, 3M Co, AbbVie, Zimmer Biomet Dominating  2021/08/18 09:13:00 Intrado Digital Media
Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market Outlook 2029" report has been added to''s offering.
   Corneal Transplant Market Recent Trends, Future Industry Growth Analysis Forecasts To 2027| CryoLife, Inc., Exactech, Inc., Köhler GmbH  2021/08/11 12:36:24 OpenPR
Corneal transplant surgery is a medical operation that replaces a portion of a patient''s cornea with corneal tissue from a donor. In reality, the cornea is the clear, dome-shaped surface of the eye. It is a huge region of the

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 CRYOLIFE CRY )


 twitter  (公式ツイッターやCEOツイッターなど)